comparemela.com

Latest Breaking News On - Lihan zhou - Page 1 : comparemela.com

MiRxes, PT Elion to Develop Cancer Tests for Indonesian Population

As part of the arrangement, PT Elion will validate MiRxes' microRNA-based tests for stomach and lung cancer in an Indonesian cohort.

MiRxes, BGI Research, MGI Partner on Spatial Genomics in Singapore

The three-way strategic partnership aims to develop a spatial multiomics pipeline to foster further regional collaborations.

Watch CEOs of life science firms Esco, MiRXES speak on global strategy

Singapore Cancer Diagnostics Startup Gets $77 Million in Funding

Singapore Cancer Diagnostics Startup Gets $77 Million in Funding Yoolim Lee, Bloomberg News (Bloomberg) Singaporean biotechnology startup MiRXES Pte raised $77 million from investors led by CR-CP Life Science Fund to deliver early detection tests for cancer and other diseases. Other backers in the Series C funding round include Rock Springs Capital, EDBI, CCB International Holdings Ltd. and Keytone Ventures, the company said in a statement. The round, which brings the total amount of money raised to date to $120 million, values the seven-year-old startup at $500 million, according to a person with knowledge of the matter who asked not to be identified.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.